Preview Mode Links will not work in preview mode

Circulation on the Run

Feb 5, 2024

This week, please join author Brendon Neuen and Editor Sandeep Das as they discuss the original research article "Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria."

For the episode transcript, visit: